TEL AVIV, Israel, Aug. 09, 2019-- InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by the.
InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency - Nasdaq
Read More
TEL AVIV, Israel, Aug. 09, 2019-- InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by the.
No comments:
Post a Comment